Company registration number 08424862 (England and Wales)
ELITE SURGICAL CARE GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024
PAGES FOR FILING WITH REGISTRAR
ELITE SURGICAL CARE GROUP LIMITED
COMPANY INFORMATION
Director
Dr M S U Hassan
Company number
08424862
Registered office
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
Accountants
Ormerod Rutter Limited
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
Bankers
The Co-operative Bank
1/2 Dudley Street
Wolverhampton
WV1 3EN
ELITE SURGICAL CARE GROUP LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3 - 5
ELITE SURGICAL CARE GROUP LIMITED
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ELITE SURGICAL CARE GROUP LIMITED FOR THE YEAR ENDED 29 FEBRUARY 2024
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Elite Surgical Care Group Limited for the year ended 29 February 2024 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of Elite Surgical Care Group Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Elite Surgical Care Group Limited and state those matters that we have agreed to state to the board of directors of Elite Surgical Care Group Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Elite Surgical Care Group Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Elite Surgical Care Group Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Elite Surgical Care Group Limited. You consider that Elite Surgical Care Group Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Elite Surgical Care Group Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Ormerod Rutter Limited
27 November 2024
Chartered Accountants
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
ELITE SURGICAL CARE GROUP LIMITED
BALANCE SHEET
AS AT
29 FEBRUARY 2024
29 February 2024
- 2 -
29 February 2024
28 February 2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
767,317
763,867
Investments
4
20
10
767,337
763,877
Current assets
Debtors
5
7,168,638
5,661,905
Cash at bank and in hand
151,982
1,224,797
7,320,620
6,886,702
Creditors: amounts falling due within one year
6
(1,349,768)
(1,149,267)
Net current assets
5,970,852
5,737,435
Net assets
6,738,189
6,501,312
Capital and reserves
Called up share capital
7
103
103
Profit and loss reserves
6,738,086
6,501,209
Total equity
6,738,189
6,501,312

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 27 November 2024
Dr M S U Hassan
Director
Company registration number 08424862 (England and Wales)
ELITE SURGICAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024
- 3 -
1
Accounting policies
Company information

Elite Surgical Care Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Oakley, Kidderminster Road, Droitwich, Worcestershire, WR9 9AY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold property
Not provided

No depreciation is provided on freehold property. This treatment may be a departure from the requirements of Companies Act 2006 concerning depreciation of fixed assets, however, the company follows a program of regular refurbishment and maintenance of its properties, which includes the reinstatement of the fabric of the buildings where necessary in order to maintain them to a high standard. Accordingly, in the opinion of the directors, any element of depreciation would be immaterial and no provision has been made, as the residual value would be in excess of cost.

1.3
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
ELITE SURGICAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY 2024
- 4 -
3
Tangible fixed assets
Freehold property
£
Cost
At 1 March 2023
763,867
Additions
3,450
At 29 February 2024
767,317
Depreciation and impairment
At 1 March 2023 and 29 February 2024
-
0
Carrying amount
At 29 February 2024
767,317
At 28 February 2023
763,867
4
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
20
10
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 March 2023
10
Additions
10
At 29 February 2024
20
Carrying amount
At 29 February 2024
20
At 28 February 2023
10
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
7,168,638
5,661,905
ELITE SURGICAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 29 FEBRUARY 2024
- 5 -
6
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
-
0
648
Amounts owed to group undertakings and undertakings in which the company has a participating interest
1,204,778
1,077,266
Other creditors
144,990
71,353
1,349,768
1,149,267
7
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A of £1 each
70
70
70
70
Ordinary B of £1 each
3
3
3
3
Ordinary C of £1 each
30
30
30
30
103
103
103
103
8
Related party transactions

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

9
Ultimate controlling party

The ultimate controlling party is Dr M S U Hassan.

2024-02-292023-03-01false27 November 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityDr M S U Hassanfalsefalse084248622023-03-012024-02-2908424862bus:Director12023-03-012024-02-2908424862bus:RegisteredOffice2023-03-012024-02-2908424862bus:Agent12023-03-012024-02-29084248622024-02-29084248622023-02-2808424862core:LandBuildingscore:OwnedOrFreeholdAssets2024-02-2908424862core:LandBuildingscore:OwnedOrFreeholdAssets2023-02-2808424862core:CurrentFinancialInstrumentscore:WithinOneYear2024-02-2908424862core:CurrentFinancialInstrumentscore:WithinOneYear2023-02-2808424862core:CurrentFinancialInstruments2024-02-2908424862core:CurrentFinancialInstruments2023-02-2808424862core:ShareCapital2024-02-2908424862core:ShareCapital2023-02-2808424862core:RetainedEarningsAccumulatedLosses2024-02-2908424862core:RetainedEarningsAccumulatedLosses2023-02-2808424862core:ShareCapitalOrdinaryShares2024-02-2908424862core:ShareCapitalOrdinaryShares2023-02-2808424862core:LandBuildingscore:OwnedOrFreeholdAssets2023-03-012024-02-29084248622022-03-012023-02-2808424862core:LandBuildingscore:OwnedOrFreeholdAssets2023-02-2808424862core:WithinOneYear2024-02-2908424862core:WithinOneYear2023-02-2808424862bus:PrivateLimitedCompanyLtd2023-03-012024-02-2908424862bus:SmallCompaniesRegimeForAccounts2023-03-012024-02-2908424862bus:FRS1022023-03-012024-02-2908424862bus:AuditExemptWithAccountantsReport2023-03-012024-02-2908424862bus:FullAccounts2023-03-012024-02-29xbrli:purexbrli:sharesiso4217:GBP